To access the full text documents, please follow this link: http://hdl.handle.net/10256/1753

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)
Ferrer Soler, Laura; Vázquez Martín, Alejandro; Brunet i Vidal, Joan; Menéndez Menéndez, Javier Abel; Llorens Duran, Rafael de; Colomer, Ramon
2009-11-27
Mama -- Càncer
Breast -- Cancer
Gefitinib
Tots els drets reservats
Article
University of Crete, Faculty of Medicine
         

Show full item record

Related documents

Other documents of the same author

Oliveras Ferrarós, Cristina; Vázquez Martín, Alejandro; Colomer, Ramon; Llorens Duran, Rafael de; Brunet i Vidal, Joan; Menéndez Menéndez, Javier Abel
Oliveras Ferrarós, Cristina; Massaguer i Vall-llovera, Anna; Vázquez Martín, Alejandro; Carrion Salip, Dolors; Queralt, Bernardo; Cufí González, Sílvia; Martin Castillo, Begoña; Bosch Barrera, Joaquim; Brunet i Vidal, Joan; Llorens Duran, Rafael de; Menéndez Menéndez, Javier Abel
Oliveras Ferrarós, Cristina; Vázquez Martín, Alejandro; Queralt, Bernardo; Adrados, Manuel; Ortiz, Rosa; Cufí González, Sílvia; Hernández Yagüe, Xavier; Guardeño, Raquel; Báez, Luciana; Martin Castillo, Begoña; Pérez Martínez, Maria Carmen; López Bonet, Eugeni; Llorens Duran, Rafael de; Bernadó, Luis; Brunet i Vidal, Joan; Menéndez Menéndez, Javier Abel
Cufí González, Sílvia; Corominas Faja, Bruna; Vázquez Martín, Alejandro; Oliveras Ferrarós, Cristina; Dorca Ribugent, Joan; Bosch Barrera, Joaquim; Martin Castillo, Begoña; Menéndez Menéndez, Javier Abel
Queralt, Bernardo; Cuyàs, Elisabet; Bosch Barrera, Joaquim; Massaguer i Vall-llovera, Anna; Llorens Duran, Rafael de; Martin Castillo, Begoña; Brunet i Vidal, Joan; Salazar, Ramon; Menéndez, Javier A.
 

Coordination

 

Supporters